Aileens Pharma srl

Biotech company developing topical, non steroidal and non pharmacological treatment for inflammatory skin diseases , especially for pediatric patients

  • Stage Full Product Ready
  • Industry Biotechnology
  • Location Milano, Metropolitan City of Milan, Italy
  • Currency EUR
  • Founded July 2018
  • Employees 6
  • Incorporation Type Not Incorporated
  • Website https://aileenspharma.com

Company Summary

We developed medical devices to treat inflammatory skin disease such as atopic dermatitis, psoriasis , radiodermatitis. It is now know the key role played by the cutaneous microbiota in the immune triggering on the most common skin illnesses. Our functional ingredient HAc40 is able to act on inflammation modulating the microbiota acting directly on the toxins released by phatogens. Product are approved in EU from zero years up.

Team

  • Founder & CEO

    previously BD manager in Sinclair pharmaceuticals , a UK company active on OBGYN and Dermatology. Founder of University spin off ( Pharmamol) Founder of Claride Pharma , company active in the R&D of prescription food supplement in the field of metabolic disorders, urinary tract infection and infertility and commercially active WW through B2B license agreements.
    Master in Pharmaceutical management , Founder of Aileens Pharma

Advisors

  • Mathieu Simon Chairman
    Unconfirmed

Previous Investors

  • Panakes Partners SGR ( venture capital)
    Unconfirmed
    CDP Ventures
    Unconfirmed

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free